Home Capital Broker's Calls

IHH Healthcare to see an exciting 2019 with increasingly palatable valuations: UOB

Michelle Zhu
Michelle Zhu5/31/2019 12:52 PM GMT+08  • 2 min read
IHH Healthcare to see an exciting 2019 with increasingly palatable valuations: UOB
SINGAPORE (May 31): UOB Kay Hian is maintaining “buy” on IHH Healthcare with a target price of RM6.30 ($2.07), which implies 32.8 times 2020F P/E – well below its historical five-year 12 month forward P/E of 57 times based on the stock’s performan
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (May 31): UOB Kay Hian is maintaining “buy” on IHH Healthcare with a target price of RM6.30 ($2.07), which implies 32.8 times 2020F P/E – well below its historical five-year 12 month forward P/E of 57 times based on the stock’s performance on the KLSE.

This comes post the release of the dual-listed healthcare services provider’s 1Q19 earnings results, which exceeded consensus estimates and serve as a precursor to an exciting 2019, says UOB analyst Philip Wong in a Friday report.

Going forward, Wong expects IHH to sustain its upward operational earnings trajectory after the group’s established markets in Singapore and Malaysia sustained “impressive growth” over 1Q. This would be further boosted by added gestation of hospitals in Pantai Manjung, Kota Kinabalu and Medini in Malaysia, he adds.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now